T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Synovus
SNV
$7.2B
| $12.2M | ﹤0.01% |
273,271
+2,714
| +1% | +$121K |
|
1102
Sana Biotechnology
SANA
$831M
| $12M | ﹤0.01% |
2,889,119
-228,877
| -7% | -$952K |
|
1103
Intellia Therapeutics
NTLA
$1.22B
| $12M | ﹤0.01% |
582,532
-662,427
| -53% | -$13.6M |
|
1104
Mohawk Industries
MHK
$8.52B
| $12M | ﹤0.01% |
74,501
+282
| +0.4% | +$45.3K |
|
1105
nVent Electric
NVT
$15.4B
| $11.9M | ﹤0.01% |
168,783
+2,958
| +2% | +$208K |
|
1106
BorgWarner
BWA
$9.48B
| $11.8M | ﹤0.01% |
325,448
-13,267
| -4% | -$481K |
|
|
BBOT
1107
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$855M
| $11.8M | ﹤0.01% |
1,127,598
-3,079
| -0.3% | -$32.2K |
|
1108
SoFi Technologies
SOFI
$31.6B
| $11.6M | ﹤0.01% |
1,476,893
+916,777
| +164% | +$7.21M |
|
1109
Fidelity National Financial
FNF
$16.5B
| $11.6M | ﹤0.01% |
186,887
-7,394
| -4% | -$459K |
|
1110
Nextracker
NXT
$9.99B
| $11.6M | ﹤0.01% |
309,241
+91,804
| +42% | +$3.44M |
|
1111
Toyota
TM
$256B
| $11.6M | ﹤0.01% |
+64,678
| New | +$11.6M |
|
1112
Aecom
ACM
$16.9B
| $11.5M | ﹤0.01% |
111,124
+18,414
| +20% | +$1.9M |
|
1113
Li Auto
LI
$24.6B
| $11.4M | ﹤0.01% |
+446,000
| New | +$11.4M |
|
1114
Paycom
PAYC
$12.5B
| $11.4M | ﹤0.01% |
68,611
+2,366
| +4% | +$394K |
|
1115
Oric Pharmaceuticals
ORIC
$1.05B
| $11.4M | ﹤0.01% |
1,114,885
-74,342
| -6% | -$762K |
|
1116
Extreme Networks
EXTR
$2.97B
| $11.3M | ﹤0.01% |
750,308
+49,586
| +7% | +$745K |
|
1117
Rapid7
RPD
$1.28B
| $11.1M | ﹤0.01% |
279,076
-241,363
| -46% | -$9.63M |
|
1118
Amdocs
DOX
$9.37B
| $11M | ﹤0.01% |
126,182
+26,761
| +27% | +$2.34M |
|
1119
Apellis Pharmaceuticals
APLS
$3.17B
| $10.9M | ﹤0.01% |
378,456
-897,970
| -70% | -$25.9M |
|
1120
Enovis
ENOV
$1.85B
| $10.9M | ﹤0.01% |
252,753
-118,395
| -32% | -$5.1M |
|
1121
Jones Lang LaSalle
JLL
$14.8B
| $10.8M | ﹤0.01% |
39,904
+2,423
| +6% | +$654K |
|
1122
Home BancShares
HOMB
$5.89B
| $10.7M | ﹤0.01% |
394,952
-16,530
| -4% | -$448K |
|
1123
Hyatt Hotels
H
$13.7B
| $10.7M | ﹤0.01% |
70,142
+7,343
| +12% | +$1.12M |
|
1124
SL Green Realty
SLG
$4.65B
| $10.7M | ﹤0.01% |
153,058
-450,779
| -75% | -$31.4M |
|
1125
Diageo
DEO
$56.6B
| $10.7M | ﹤0.01% |
75,893
+39,952
| +111% | +$5.61M |
|